Metformin : : pharmacology and drug interactions / / Juber Akhtar [and three others], editor.
Type 2 diabetes (T2D), also known as non-insulin-dependent diabetes mellitus (NIDDM), is a condition in which cells fail to respond to insulin properly. As the disease progresses, the body does not produce enough insulin. There are several classes of anti-diabetic medications available, including th...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | London : : IntechOpen,, 2021. |
Year of Publication: | 2021 |
Language: | English |
Physical Description: | 1 online resource (154 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993603420804498 |
---|---|
ctrlnum |
(CKB)5400000000044877 (NjHacI)995400000000044877 (EXLCZ)995400000000044877 |
collection |
bib_alma |
record_format |
marc |
spelling |
Metformin : pharmacology and drug interactions / Juber Akhtar [and three others], editor. Metformin London : IntechOpen, 2021. 1 online resource (154 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on publisher supplied metadata and other sources. Type 2 diabetes (T2D), also known as non-insulin-dependent diabetes mellitus (NIDDM), is a condition in which cells fail to respond to insulin properly. As the disease progresses, the body does not produce enough insulin. There are several classes of anti-diabetic medications available, including the oral agent metformin. This medication is recommended as first-line treatment for T2D, except for those patients with severe kidney or liver problems. This book discusses the molecular mechanism, pharmacokinetics, and uses of metformin, as well as presents information on adverse drug reactions, drug interactions, and the potential use of metformin in tuberculosis. Metformin. 1-83969-607-9 Akhtar, Juber, editor. |
language |
English |
format |
eBook |
author2 |
Akhtar, Juber, |
author_facet |
Akhtar, Juber, |
author2_variant |
j a ja |
author2_role |
TeilnehmendeR |
title |
Metformin : pharmacology and drug interactions / |
spellingShingle |
Metformin : pharmacology and drug interactions / |
title_sub |
pharmacology and drug interactions / |
title_full |
Metformin : pharmacology and drug interactions / Juber Akhtar [and three others], editor. |
title_fullStr |
Metformin : pharmacology and drug interactions / Juber Akhtar [and three others], editor. |
title_full_unstemmed |
Metformin : pharmacology and drug interactions / Juber Akhtar [and three others], editor. |
title_auth |
Metformin : pharmacology and drug interactions / |
title_alt |
Metformin |
title_new |
Metformin : |
title_sort |
metformin : pharmacology and drug interactions / |
publisher |
IntechOpen, |
publishDate |
2021 |
physical |
1 online resource (154 pages) |
isbn |
1-83969-607-9 |
callnumber-first |
Q - Science |
callnumber-subject |
QP - Physiology |
callnumber-label |
QP801 |
callnumber-sort |
QP 3801 M39 M484 42021 |
illustrated |
Not Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616.462061 |
dewey-sort |
3616.462061 |
dewey-raw |
616.462061 |
dewey-search |
616.462061 |
work_keys_str_mv |
AT akhtarjuber metforminpharmacologyanddruginteractions AT akhtarjuber metformin |
status_str |
n |
ids_txt_mv |
(CKB)5400000000044877 (NjHacI)995400000000044877 (EXLCZ)995400000000044877 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Metformin : pharmacology and drug interactions / |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1796653218153889792 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01552nam a2200277 i 4500</leader><controlfield tag="001">993603420804498</controlfield><controlfield tag="005">20230701032349.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230701s2021 enk o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000044877</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995400000000044877</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000044877</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QP801.M39</subfield><subfield code="b">.M484 2021</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.462061</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Metformin :</subfield><subfield code="b">pharmacology and drug interactions /</subfield><subfield code="c">Juber Akhtar [and three others], editor.</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Metformin </subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">2021.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (154 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Type 2 diabetes (T2D), also known as non-insulin-dependent diabetes mellitus (NIDDM), is a condition in which cells fail to respond to insulin properly. As the disease progresses, the body does not produce enough insulin. There are several classes of anti-diabetic medications available, including the oral agent metformin. This medication is recommended as first-line treatment for T2D, except for those patients with severe kidney or liver problems. This book discusses the molecular mechanism, pharmacokinetics, and uses of metformin, as well as presents information on adverse drug reactions, drug interactions, and the potential use of metformin in tuberculosis.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Metformin.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-83969-607-9</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Akhtar, Juber,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-07-08 12:18:52 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5351665950004498&Force_direct=true</subfield><subfield code="Z">5351665950004498</subfield><subfield code="b">Available</subfield><subfield code="8">5351665950004498</subfield></datafield></record></collection> |